Bio-Techne’s Ella Added to BioAgilytix Portfolio of Industry-Leading Immunoassay Platforms
Wednesday, February 07, 2018 - 10:49
Bio-Techne’s ProteinSimple-branded Ella™ platform has recently been added to the suite of advanced immunoassay technology at BioAgilytix, a leading provider of contract bioanalytical testing services with specialization in large molecule bioanalysis.
Ella joins her other immunoassay platform from ProteinSimple, PeggySue®, along with several other bioanalytical technologies and automation systems in the BioAgilytix core immunoassay services in their laboratories.
"As we continue to grow our expert scientific staff, and the platforms that will optimally support their studies, we are continuing to position BioAgilytix as the premier large molecule bioanalytical laboratory and biomarker service provider. The addition of Ella to our portfolio of immunoassay platforms better prepares us to address multiplex biomarker analysis challenges effectively."
- Jim Datin, Chief Executive Officer of BioAgilytix.
Bio-Techne is proud to aid in BioAgilytix's commitment to effectively addressing customers' evolving biomarker assay needs, and Ella will be used to support multiplex biomarker analysis in cases where assay variability and antibody cross-reactivity are of particular concern.
Read more about Ella, BioAgilytix, and Bio-Techne’s commitment to researchers’ needs in our latest press release.